Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$284K Buy
69,110
+1,119
+2% +$5.42K ﹤0.01% 2531
2025
Q4
$452K Sell
67,991
-72,782
-52% -$493K 0.01% 1697
2025
Q3
$864K Buy
140,773
+58,426
+71% +$456K 0.04% 669
2025
Q2
$758K Buy
82,347
+20,665
+34% +$211K 0.03% 833
2025
Q1
$742K Buy
+61,682
New +$807K 0.04% 736
2024
Q1
Sell
-39,453
Closed -$415K 1962
2023
Q4
$415K Buy
+39,453
New +$353K 0.09% 376
2022
Q1
Sell
-15,453
Closed -$101K 743
2021
Q4
$101K Buy
+15,453
New +$106K 0.06% 465

Other funds holding EOLS

XTX Topco's EOLS Position: Q1 2026 in Review

XTX Topco increased its Evolus (EOLS) stake by 1.6% in Q1 2026, buying an estimated $5.42K and bringing the position to 69,110 shares worth $284K. The position accounts for ﹤0.01% of the portfolio, ranked #2531.

XTX Topco first reported a position in EOLS in Q4 2021 and has held it in 7 quarters since. The position peaked at $864K in Q3 2025. 147 funds tracked by Wall St. Rank hold EOLS as of Q1 2026.

  • XTX Topco held 69,110 shares of Evolus worth $284K as of Q1 2026.
  • XTX Topco bought 1,119 Evolus shares in Q1 2026, an estimated $5.42K.
  • Evolus made up ﹤0.01% of XTX Topco's portfolio in Q1 2026, its #2531 holding.
  • XTX Topco first reported a position in Evolus in Q4 2021 and has held it in 7 quarters since.
  • XTX Topco's Evolus position peaked at $864K in Q3 2025.
  • 147 funds tracked by Wall St. Rank held Evolus as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.